-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12

Benzinga·09/23/2026 10:45:01
Diffusion vocale
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and raises the price target from $11 to $12.